VMC
33
3
STI
46
-4
MMM
42
5
CPB
32
-2
SBUX
48
13
WU
28
2
MDT
59
2
FFIV
60
2
TDC
55
-2
GPC
38
3
FLS
60
5
PM
56
6
CMA
50
4
GT
41
2
HBAN
54
3
AES
49
3
SCHW
45
2
BA
42
-2
BSX
64
3
ABBV
53
3
VMC
33
3
STI
46
-4
MMM
42
5
CPB
32
-2
SBUX
48
13
WU
28
2
MDT
59
2
FFIV
60
2
TDC
55
-2
GPC
38
3
FLS
60
5
PM
56
6
CMA
50
4
GT
41
2
HBAN
54
3
AES
49
3
SCHW
45
2
BA
42
-2
BSX
64
3
ABBV
53
3
Financhill
Back

Guggenheim Strategic Opportunities Fund Vs. NovoCure Industry Stock Comparison

Buy
72

GOF
Guggenheim Strategic Opportunities Fund

Last Price:
$15.42
Seasonality Move:
1.88%
Sell
49

NVCR
NovoCure

Last Price:
$30.18
Seasonality Move:
-3.69%
Buy
72
Guggenheim Strategic Opportunities Fund (GOF) is a Buy

Is Guggenheim Strategic Opportunities Fund a Buy, Sell or Hold?

  • The current Guggenheim Strategic Opportunities Fund [GOF] share price is $15.40. The Score for GOF is 72, which is 44% above its historic median score of 50, and infers lower risk than normal.
  • GOF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
NovoCure (NVCR) is a Sell

Is NovoCure a Buy, Sell or Hold?

  • The current NovoCure [NVCR] share price is $30.19. The Score for NVCR is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
  • NVCR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

GOF Stock Price Chart

What is Guggenheim Strategic Opportunities Fund's stock price today?

NVCR Stock Price Chart

What is NovoCure's stock price today?

  • The NovoCure share price today is $30.19
    The current trend is moderately bullish and NVCR is experiencing slight selling pressure.

GOF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 47.15 Sell
Chaikin Money Flow: -73098 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (15.22 - 15.8) Sell
Bollinger Bands (100): (15.37 - 15.87) Sell

NVCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.94 Buy
Relative Strength Index (14 RSI): 58.79 Buy
Chaikin Money Flow: -60501 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.36 - 32.64) Buy
Bollinger Bands (100): (14.38 - 25.86) Buy

GOF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 15.29 Buy
20-day SMA: 15.43 Sell
50-day SMA: 15.65 Sell
200-day SMA: 15.18 Buy
8-day EMA: 15.31 Buy
20-day EMA: 15.41 Sell
50-day EMA: 15.55 Sell
200-day EMA: 15.27 Buy

NVCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 30.52 Sell
20-day SMA: 30.41 Sell
50-day SMA: 23.25 Buy
200-day SMA: 18.89 Buy
8-day EMA: 30.36 Sell
20-day EMA: 29.22 Buy
50-day EMA: 25.18 Buy
200-day EMA: 21.21 Buy

Guggenheim Strategic Opportunities Fund Earnings Growth & GOF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

NovoCure Earnings Growth & NVCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.31 per share, and an increase next year of $0.06 per share.

Guggenheim Strategic Opportunities Fund Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

NovoCure Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):